Carmellose Sodium 0.5 Eye Drops, Carmize Lubricant Ophthalmic Solution 10ml (2 x 10ml Bottles)

Product Information

At the time of writing there is limited published experience regarding the safety of carmellose sodium in human pregnancy, however, carmellose sodium eye drops have been used for many years with no adverse effects reported and the manufacturer states no special precautions are necessary during pregnancy. Schaefer advises that artificial tears may be used for all appropriate indications during pregnancy (Schaefer 2007).

Please take care that the dropper doesn't touch your eye, your fingers, or any other surface. This could contaminate the drops left in the bottle. Uncommon: Superficial injury of eye ( from the vial tip touching the eye during administration) and/or corneal abrasionThe frequency of adverse reactions documented during clinical trials is given. The frequency is defined as follows: Very Common (≥ 1/10); Common (≥1/100, <1/10); Uncommon (≥1/1,000, <1/100); Rare (≥1/10,000, <1/1,000); Very Rare (<1/10,000), not known (cannot be estimated from the available data).

The following adverse reactions have been identified during clinical studies of 0.5% w/v and 1.0% w/v Celluvisc Eye drops, solution, unit dose. Summary of Product Characteristics: Celluvisc 0.5% w/v eye drops solution. Allergan Ltd. Revised May 2010.Common: Eye irritation (including burning and discomfort), eye pain, eye pruritus, visual disturbance. The following additional adverse reactions have been identified during postmarketing use of Celluvisc 1.0% in clinical practice.